Intranasal Peptide Therapeutics: A Promising Avenue for Overcoming the Challenges of Traditional CNS Drug Development
出版年份 2022 全文链接
标题
Intranasal Peptide Therapeutics: A Promising Avenue for Overcoming the Challenges of Traditional CNS Drug Development
作者
关键词
-
出版物
Cells
Volume 11, Issue 22, Pages 3629
出版商
MDPI AG
发表日期
2022-11-17
DOI
10.3390/cells11223629
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- SH3- and actin-binding domains connect ADNP and SHANK3, revealing a fundamental shared mechanism underlying autism
- (2022) Yanina Ivashko-Pachima et al. MOLECULAR PSYCHIATRY
- Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System
- (2022) Tyler P. Crowe et al. Pharmaceutics
- Combined Oxytocin and Cognitive Behavioral Social Skills Training for Social Function in People With Schizophrenia
- (2021) Robert W. Buchanan et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Introducing ADNP and SIRT1 as new partners regulating microtubules and histone methylation
- (2021) Adva Hadar et al. MOLECULAR PSYCHIATRY
- Intranasal oxytocin administration ameliorates social behavioral deficits in a POGZWT/Q1038R mouse model of autism spectrum disorder
- (2021) Kohei Kitagawa et al. Molecular Brain
- Randomized clinical trial shows no substantial modulation of empathy-related neural activation by intranasal oxytocin in autism
- (2021) Annalina V. Mayer et al. Scientific Reports
- Emerging trends in the delivery of nanoformulated oxytocin across Blood-Brain barrier
- (2021) Ebtesam Abdullah Al-Suhaimi et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Effects of intranasal oxytocin on threat- and reward-related functional connectivity in men and women with and without childhood abuse-related PTSD
- (2021) Lauren M. Sippel et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- Novel ADNP Syndrome Mice Reveal Dramatic Sex-Specific Peripheral Gene Expression With Brain Synaptic and Tau Pathologies
- (2021) Gidon Karmon et al. BIOLOGICAL PSYCHIATRY
- Microbiota changes associated with ADNP deficiencies: rapid indicators for NAP (CP201) treatment of the ADNP syndrome and beyond
- (2020) Oxana Kapitansky et al. JOURNAL OF NEURAL TRANSMISSION
- Sex as a Biological Variable: A 5-Year Progress Report and Call to Action
- (2020) Matthew E. Arnegard et al. JOURNAL OF WOMENS HEALTH
- Effects of intranasal insulin as an enhancer of fear extinction: a randomized, double-blind, placebo-controlled experimental study
- (2020) Diana S. Ferreira de Sá et al. NEUROPSYCHOPHARMACOLOGY
- Behavioral effects of multiple-dose oxytocin treatment in autism: a randomized, placebo-controlled trial with long-term follow-up
- (2020) Sylvie Bernaerts et al. Molecular Autism
- SIRT1 and aging related signaling pathways
- (2020) Cui Chen et al. MECHANISMS OF AGEING AND DEVELOPMENT
- Role of Insulin Resistance in the Alzheimer's Disease Progression
- (2020) Thuy Trang Nguyen et al. NEUROCHEMICAL RESEARCH
- Oxytocin biases eye-gaze to dynamic and static social images and the eyes of fearful faces: associations with trait autism
- (2020) Jiao Le et al. Translational Psychiatry
- Intranasal insulin ameliorates cognitive impairment in a rat model of Parkinson's disease through Akt/GSK3β signaling pathway
- (2020) Liying Yang et al. LIFE SCIENCES
- Effect of intranasal administration of neuropeptide Y and single prolonged stress on food consumption and body weight in male rats
- (2020) Lidia I. Serova et al. NEUROPEPTIDES
- Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia
- (2020) Suzanne Craft et al. JAMA Neurology
- Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions
- (2020) Mara Dierssen et al. Frontiers in Neuroscience
- A Randomized Controlled Trial of Intranasal Neuropeptide Y in Patients With Major Depressive Disorder
- (2020) Aleksander A Mathé et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Just how prevalent are peptide therapeutic products? A critical review
- (2020) Yajie Zhang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Neural effects of oxytocin and mimicry in frontotemporal dementia
- (2020) Lindsay D. Oliver et al. NEUROLOGY
- Changes in endogenous oxytocin levels after intranasal oxytocin treatment in adult men with autism: An exploratory study with long-term follow-up
- (2020) Kaat Alaerts et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The autism/neuroprotection-linked ADNP/NAP regulate the excitatory glutamatergic synapse
- (2019) Shlomo Sragovich et al. Translational Psychiatry
- Small molecules as central nervous system therapeutics: old challenges, new directions, and a philosophic divide
- (2019) William A Banks et al. Future Medicinal Chemistry
- Single prolonged stress PTSD model triggers progressive severity of anxiety, altered gene expression in locus coeruleus and hypothalamus and effected sensitivity to NPY
- (2019) Lidia I. Serova et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Safety and preliminary efficacy of intranasal insulin for cognitive impairment in Parkinson disease and multiple system atrophy: A double-blinded placebo-controlled pilot study
- (2019) Peter Novak et al. PLoS One
- Preclinical findings on the potential of intranasal neuropeptide Y for treating hyperarousal features of PTSD
- (2019) Chiso Nwokafor et al. Annals of the New York Academy of Sciences
- Insulin resistance takes center stage: a new paradigm in the progression of bipolar disorder
- (2019) Cynthia V. Calkin ANNALS OF MEDICINE
- Oxytocin increases eye gaze in schizophrenia
- (2019) Ellen R. Bradley et al. SCHIZOPHRENIA RESEARCH
- Perivascular and Perineural Pathways Involved in Brain Delivery and Distribution of Drugs after Intranasal Administration
- (2019) Jeffrey J. Lochhead et al. Pharmaceutics
- Activation of NPY receptor subtype 1 by [D-His26]NPY is sufficient to prevent development of anxiety and depressive like effects in the single prolonged stress rodent model of PTSD
- (2019) Chiso Nwokafor et al. NEUROPEPTIDES
- Intranasal delivery of low-dose insulin ameliorates motor dysfunction and dopaminergic cell death in a 6-OHDA rat model of Parkinson’s Disease
- (2019) Jared M. Fine et al. NEUROSCIENCE LETTERS
- Therapeutic peptides for CNS indications: Progress and challenges
- (2018) Bruce H. Morimoto BIOORGANIC & MEDICINAL CHEMISTRY
- Discovery of PACAP and its receptors in the brain
- (2018) Takahiro Hirabayashi et al. JOURNAL OF HEADACHE AND PAIN
- Mechanisms underlying the role of DISC1 in synaptic plasticity
- (2018) Daniela Tropea et al. JOURNAL OF PHYSIOLOGY-LONDON
- Augmenting Prolonged Exposure therapy for PTSD with intranasal oxytocin: A randomized, placebo-controlled pilot trial
- (2018) Julianne C. Flanagan et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Potential of Intranasal Neuropeptide Y (NPY) and/or Melanocortin 4 Receptor (MC4R) Antagonists for Preventing or Treating PTSD
- (2018) Esther L Sabban et al. MILITARY MEDICINE
- Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Enhances Hippocampal Synaptic Plasticity and Improves Memory Performance in Huntington’s Disease
- (2018) N. Cabezas-Llobet et al. MOLECULAR NEUROBIOLOGY
- Cardiovascular responses to intranasal neuropeptide Y in single prolonged stress rodent model of post-traumatic stress disorder
- (2018) Robert Camp et al. NEUROPEPTIDES
- Overview of intranasally delivered peptides: key considerations for pharmaceutical development
- (2018) Wisam Al Bakri et al. Expert Opinion on Drug Delivery
- Direct and indirect evidences of BDNF and NGF as key modulators in depression: Role of antidepressants treatment
- (2018) Amal Chandra Mondal et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- A Randomized Controlled Trial of High-Dose Vitamin D2 Followed by Intranasal Insulin in Alzheimer's Disease
- (2018) Mark S. Stein et al. JOURNAL OF ALZHEIMERS DISEASE
- Sex and ApoE Genotype Differences in Treatment Response to Two Doses of Intranasal Insulin in Adults with Mild Cognitive Impairment or Alzheimer's Disease
- (2018) Amy Claxton et al. JOURNAL OF ALZHEIMERS DISEASE
- Effects of oxytocin on empathy, introspective accuracy, and social symptoms in schizophrenia: A 12-week twice-daily randomized controlled trial
- (2018) Tate Halverson et al. SCHIZOPHRENIA RESEARCH
- Effects of intranasal oxytocin on distraction as emotion regulation strategy in patients with post-traumatic stress disorder
- (2018) Saskia B.J. Koch et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Advanced formulations for intranasal delivery of biologics
- (2018) Julia Rohrer et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Neural modulation of social reinforcement learning by intranasal oxytocin in male adults with high-functioning autism spectrum disorder: a randomized trial
- (2018) Jana A. Kruppa et al. NEUROPSYCHOPHARMACOLOGY
- Effective nose-to-brain delivery of exendin-4 via coadministration with cell-penetrating peptides for improving progressive cognitive dysfunction
- (2018) Noriyasu Kamei et al. Scientific Reports
- Intranasal insulin activates Akt2 signaling pathway in the hippocampus of wild-type but not in APP/PS1 Alzheimer model mice
- (2018) Sami Gabbouj et al. NEUROBIOLOGY OF AGING
- Oxytocin attenuates deficits in social interaction but not recognition memory in a prenatal valproic acid-induced mouse model of autism
- (2017) Yuta Hara et al. HORMONES AND BEHAVIOR
- A Randomized Dose-Ranging Study of Neuropeptide Y in Patients with Posttraumatic Stress Disorder
- (2017) Sehrish Sayed et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- A randomized, double-blind, placebo-controlled, crossover trial evaluating the effect of intranasal insulin on cognition and mood in individuals with treatment-resistant major depressive disorder
- (2017) Danielle S. Cha et al. JOURNAL OF AFFECTIVE DISORDERS
- Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer’s Disease Biomarkers: A Pilot Clinical Trial
- (2017) Suzanne Craft et al. JOURNAL OF ALZHEIMERS DISEASE
- Intranasal Administration of TAT-Conjugated Lipid Nanocarriers Loading GDNF for Parkinson’s Disease
- (2017) Sara Hernando et al. MOLECULAR NEUROBIOLOGY
- The need for new approaches in CNS drug discovery: Why drugs have failed, and what can be done to improve outcomes
- (2017) Valentin K. Gribkoff et al. NEUROPHARMACOLOGY
- Intranasal insulin treatment alleviates methamphetamine induced anxiety-like behavior and neuroinflammation
- (2017) Elmira Beirami et al. NEUROSCIENCE LETTERS
- Intranasal Insulin Ameliorates Cerebral Hypometabolism, Neuronal Loss, and Astrogliosis in Streptozotocin-Induced Alzheimer’s Rat Model
- (2017) Yanxing Chen et al. NEUROTOXICITY RESEARCH
- Intranasal oxytocin does not modulate jumping to conclusions in schizophrenia: Potential interactions with caudate volume and baseline social functioning
- (2017) Fernando Caravaggio et al. PSYCHONEUROENDOCRINOLOGY
- A 12-week randomized controlled trial of twice-daily intranasal oxytocin for social cognitive deficits in people with schizophrenia
- (2017) L. Fredrik Jarskog et al. SCHIZOPHRENIA RESEARCH
- Dose-dependent social-cognitive effects of intranasal oxytocin delivered with novel Breath Powered device in adults with autism spectrum disorder: a randomized placebo-controlled double-blind crossover trial
- (2017) D S Quintana et al. Translational Psychiatry
- Nuclear Factor-Kappa B and Alzheimer Disease, Unifying Genetic and Environmental Risk Factors from Cell to Humans
- (2017) Simon Vann Jones et al. Frontiers in Immunology
- Long-term treatment with intranasal insulin ameliorates cognitive impairment, tau hyperphosphorylation and microglial activation in a streptozotocin-induced Alzheimer’s rat model
- (2017) Zhangyu Guo et al. Scientific Reports
- Intranasal insulin alleviates cognitive deficits and amyloid pathology in young adult APPswe/PS1dE9 mice
- (2016) Yan-Fang Mao et al. AGING CELL
- Is there an effect of intranasal insulin on development and behaviour in Phelan-McDermid syndrome? A randomized, double-blind, placebo-controlled trial
- (2016) Renée J Zwanenburg et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Intranasal Administration of Chitosan-Coated Nanostructured Lipid Carriers Loaded with GDNF Improves Behavioral and Histological Recovery in a Partial Lesion Model of Parkinson's Disease
- (2016) O. Gartziandia et al. Journal of Biomedical Nanotechnology
- Intranasal Insulin Administration Ameliorates Streptozotocin (ICV)-Induced Insulin Receptor Dysfunction, Neuroinflammation, Amyloidogenesis, and Memory Impairment in Rats
- (2016) N. Rajasekar et al. MOLECULAR NEUROBIOLOGY
- Small molecules, big targets: drug discovery faces the protein–protein interaction challenge
- (2016) Duncan E. Scott et al. NATURE REVIEWS DRUG DISCOVERY
- Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats
- (2016) Y. Pang et al. NEUROSCIENCE
- Intranasal oxytocin enhances neural processing of monetary reward and loss in post-traumatic stress disorder and traumatized controls
- (2016) Laura Nawijn et al. PSYCHONEUROENDOCRINOLOGY
- Do we need oxytocin to treat schizophrenia? A randomized clinical trial
- (2016) Jessica Dagani et al. SCHIZOPHRENIA RESEARCH
- Intranasal oxytocin increases neural responses to social reward in post-traumatic stress disorder
- (2016) Laura Nawijn et al. Social Cognitive and Affective Neuroscience
- Intranasal Delivery of Recombinant AAV Containing BDNF Fused with HA2TAT: a Potential Promising Therapy Strategy for Major Depressive Disorder
- (2016) Xian-cang Ma et al. Scientific Reports
- Oxytocin efficacy is modulated by dosage and oxytocin receptor genotype in young adults with high-functioning autism: a 24-week randomized clinical trial
- (2016) H Kosaka et al. Translational Psychiatry
- Intranasal Oxytocin Enhances Connectivity in the Neural Circuitry Supporting Social Motivation and Social Perception in Children with Autism
- (2016) Ilanit Gordon et al. Scientific Reports
- Comparative effects of intranasal neuropeptide Y and HS014 in preventing anxiety and depressive-like behavior elicited by single prolonged stress
- (2015) Esther L. Sabban et al. BEHAVIOURAL BRAIN RESEARCH
- Peptide therapeutics: Targeting the undruggable space
- (2015) Natia Tsomaia EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Intranasal delivery: circumventing the iron curtain to treat neurological disorders
- (2015) Yongjun Jiang et al. Expert Opinion on Drug Delivery
- Locus coeruleus response to single-prolonged stress and early intervention with intranasal neuropeptide Y
- (2015) Esther L. Sabban et al. JOURNAL OF NEUROCHEMISTRY
- Comparative Biodistribution and Pharmacokinetic Analysis of Cyclosporine-A in the Brain upon Intranasal or Intravenous Administration in an Oil-in-Water Nanoemulsion Formulation
- (2015) Sunita Yadav et al. MOLECULAR PHARMACEUTICS
- Hippocampal insulin resistance and cognitive dysfunction
- (2015) Geert Jan Biessels et al. NATURE REVIEWS NEUROSCIENCE
- Intranasal Oxytocin Administration Dampens Amygdala Reactivity towards Emotional Faces in Male and Female PTSD Patients
- (2015) Saskia BJ Koch et al. NEUROPSYCHOPHARMACOLOGY
- Intranasal Oxytocin Affects Amygdala Functional Connectivity after Trauma Script-Driven Imagery in Distressed Recently Trauma-Exposed Individuals
- (2015) Jessie L Frijling et al. NEUROPSYCHOPHARMACOLOGY
- Effects of Oxytocin on Neural Response to Facial Expressions in Patients with Schizophrenia
- (2015) Na Young Shin et al. NEUROPSYCHOPHARMACOLOGY
- Effects of intranasal oxytocin on amygdala reactivity to emotional faces in recently trauma-exposed individuals
- (2015) Jessie L Frijling et al. Social Cognitive and Affective Neuroscience
- Risperidone and NAP protect cognition and normalize gene expression in a schizophrenia mouse model
- (2015) Sinaya Vaisburd et al. Scientific Reports
- Association of Pituitary Adenylate Cyclase–Activating Polypeptide With Cognitive Decline in Mild Cognitive Impairment Due to Alzheimer Disease
- (2015) Pengcheng Han et al. JAMA Neurology
- Oxytocin increases eye contact during a real-time, naturalistic social interaction in males with and without autism
- (2015) B Auyeung et al. Translational Psychiatry
- New horizons in schizophrenia treatment: autophagy protection is coupled with behavioral improvements in a mouse model of schizophrenia
- (2014) Avia Merenlender-Wagner et al. Autophagy
- A Single-Dose Pilot Trial of Intranasal Rapid-Acting Insulin in Apolipoprotein E4 Carriers with Mild–Moderate Alzheimer’s Disease
- (2014) Michael H. Rosenbloom et al. CNS DRUGS
- Early Intervention With Intranasal NPY Prevents Single Prolonged Stress-Triggered Impairments in Hypothalamus and Ventral Hippocampus in Male Rats
- (2014) Marcela Laukova et al. ENDOCRINOLOGY
- Intranasal delivery of systemic-acting drugs: Small-molecules and biomacromolecules
- (2014) Ana Fortuna et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Insulin reverses anxiety-like behavior evoked by streptozotocin-induced diabetes in mice
- (2014) Deepali Gupta et al. METABOLIC BRAIN DISEASE
- Oxytocin for frontotemporal dementia: A randomized dose-finding study of safety and tolerability
- (2014) E. C. Finger et al. NEUROLOGY
- Oxytocin-Augmented Social Cognitive Skills Training in Schizophrenia
- (2014) Michael C Davis et al. NEUROPSYCHOPHARMACOLOGY
- Oxytocin Modulation of Amygdala Functional Connectivity to Fearful Faces in Generalized Social Anxiety Disorder
- (2014) Stephanie M Gorka et al. NEUROPSYCHOPHARMACOLOGY
- Modulation of Resting-State Amygdala-Frontal Functional Connectivity by Oxytocin in Generalized Social Anxiety Disorder
- (2014) Sonam Dodhia et al. NEUROPSYCHOPHARMACOLOGY
- Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson’s disease
- (2014) M.M. Migliore et al. NEUROSCIENCE
- Oxytocin does not improve performance of patients with schizophrenia and healthy volunteers in a facial emotion matching task
- (2014) Ligia R. Horta de Macedo et al. PSYCHIATRY RESEARCH
- Oxytocin administration enhances controlled social cognition in patients with schizophrenia
- (2014) J.D. Woolley et al. PSYCHONEUROENDOCRINOLOGY
- A pilot controlled trial of insulin-like growth factor-1 in children with Phelan-McDermid syndrome
- (2014) Alexander Kolevzon et al. Molecular Autism
- Protein–protein interactions: switch from classical methods to proteomics and bioinformatics-based approaches
- (2013) Armand G. Ngounou Wetie et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- A Double-Blind, Placebo-Controlled, Ascending-Dose, Randomized Study to Evaluate the Safety, Tolerability and Effects on Cognition of AL-108 after 12 Weeks of Intranasal Administration in Subjects with Mild Cognitive Impairment
- (2013) Bruce H. Morimoto et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Intranasal neuropeptide Y reverses anxiety and depressive-like behavior impaired by single prolonged stress PTSD model
- (2013) L.I. Serova et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The current development of CNS drug research
- (2013) Gregers Wegener et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- No Effect of Adjunctive, Repeated-Dose Intranasal Insulin Treatment on Psychopathology and Cognition in Patients With Schizophrenia
- (2013) Xiaoduo Fan et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Intranasal formulation of erythropoietin (EPO) showed potent protective activity against amyloid toxicity in the Aβ25-35 non-transgenic mouse model of Alzheimer’s disease
- (2013) Tangui Maurice et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Brain Insulin Dysregulation: Implication for Neurological and Neuropsychiatric Disorders
- (2013) Rasoul Ghasemi et al. MOLECULAR NEUROBIOLOGY
- IGF-1 Intranasal Administration Rescues Huntington's Disease Phenotypes in YAC128 Mice
- (2013) Carla Lopes et al. MOLECULAR NEUROBIOLOGY
- NAP (davunetide) modifies disease progression in a mouse model of severe neurodegeneration: Protection against impairments in axonal transport
- (2013) Yan Jouroukhin et al. NEUROBIOLOGY OF DISEASE
- Chronic and Acute Intranasal Oxytocin Produce Divergent Social Effects in Mice
- (2013) Huiping Huang et al. NEUROPSYCHOPHARMACOLOGY
- Single intranasal neuropeptide Y infusion attenuates development of PTSD-like symptoms to traumatic stress in rats
- (2013) L.I. Serova et al. NEUROSCIENCE
- Oxytocin enhances brain function in children with autism
- (2013) I. Gordon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- No effect of adjunctive, repeated dose intranasal insulin treatment on body metabolism in patients with schizophrenia
- (2013) Jie Li et al. SCHIZOPHRENIA RESEARCH
- Improving social perception in schizophrenia: The role of oxytocin
- (2013) M. Fischer-Shofty et al. SCHIZOPHRENIA RESEARCH
- Effects of single dose intranasal oxytocin on social cognition in schizophrenia
- (2013) Michael C. Davis et al. SCHIZOPHRENIA RESEARCH
- A randomized, double-blind, controlled trial evaluating the effect of intranasal insulin on neurocognitive function in euthymic patients with bipolar disorder
- (2012) Roger S McIntyre et al. BIPOLAR DISORDERS
- Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline
- (2012) Konrad Talbot et al. JOURNAL OF CLINICAL INVESTIGATION
- PACAP is an Endogenous Protective Factor—Insights from PACAP-Deficient Mice
- (2012) D. Reglodi et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Dendritic spine pathology in schizophrenia
- (2012) J.R. Glausier et al. NEUROSCIENCE
- Intranasal administration of PACAP: Uptake by brain and regional brain targeting with cyclodextrins
- (2012) Naoko Nonaka et al. PEPTIDES
- Intranasal Treatment of Central Nervous System Dysfunction in Humans
- (2012) Colin D. Chapman et al. PHARMACEUTICAL RESEARCH
- Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors
- (2012) Inga D. Neumann et al. TRENDS IN NEUROSCIENCES
- Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment
- (2011) Suzanne Craft ARCHIVES OF NEUROLOGY
- Downregulation of hypothalamic insulin receptor expression elicits depressive-like behaviors in rats
- (2011) Claudia A. Grillo et al. BEHAVIOURAL BRAIN RESEARCH
- Insulin dysfunction and allostatic load in bipolar disorder
- (2011) Elisa Brietzke et al. Expert Review of Neurotherapeutics
- Neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) slows down Alzheimer's disease-like pathology in amyloid precursor protein-transgenic mice
- (2011) Dorothea Rat et al. FASEB JOURNAL
- Medial frontal hyperactivity to sad faces in generalized social anxiety disorder and modulation by oxytocin
- (2011) Izelle Labuschagne et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- No Effect of Single-Dose Intranasal Insulin Treatment on Verbal Memory and Sustained Attention in Patients With Schizophrenia
- (2011) Xiaoduo Fan et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine
- (2011) Andreas Meyer-Lindenberg et al. NATURE REVIEWS NEUROSCIENCE
- Davunetide (NAP) as a preventative treatment for central nervous system complications in a diabetes rat model
- (2011) Anat Idan-Feldman et al. NEUROBIOLOGY OF DISEASE
- Divergent effects of two different doses of intranasal oxytocin on facial affect discrimination in schizophrenic patients with and without polydipsia
- (2011) Morris B. Goldman et al. PSYCHOPHARMACOLOGY
- Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia
- (2011) Daniel C. Javitt et al. SCHIZOPHRENIA RESEARCH
- Regulation of erythropoietin production
- (2010) Wolfgang Jelkmann JOURNAL OF PHYSIOLOGY-LONDON
- A pilot trial of the microtubule-interacting peptide (NAP) in mice overexpressing alpha-synuclein shows improvement in motor function and reduction of alpha-synuclein inclusions
- (2010) Sheila M. Fleming et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Intranasal Administration of Nerve Growth Factor Produces Antidepressant-Like Effects in Animals
- (2010) Cui-ge Shi et al. NEUROCHEMICAL RESEARCH
- Oxytocin Attenuates Amygdala Reactivity to Fear in Generalized Social Anxiety Disorder
- (2010) Izelle Labuschagne et al. NEUROPSYCHOPHARMACOLOGY
- NAP (davunetide) enhances cognitive behavior in the STOP heterozygous mouse—A microtubule-deficient model of schizophrenia
- (2010) Avia Merenlender-Wagner et al. PEPTIDES
- Addressing Alzheimers Disease Tangles: From NAP to AL-108
- (2009) Illana Gozes et al. Current Alzheimer Research
- Chromosome 22q13.3 deletion syndrome with a de novo interstitial 22q13.3 cryptic deletion disrupting SHANK3
- (2009) A. Delahaye et al. European Journal of Medical Genetics
- NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model
- (2009) Natalia Shiryaev et al. NEUROBIOLOGY OF DISEASE
- Neuropeptide Y: Its multiple effects in the CNS and potential clinical significance
- (2009) E. E. Benarroch NEUROLOGY
- A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder
- (2009) Adam J. Guastella et al. PSYCHONEUROENDOCRINOLOGY
- The Effects of Galantamine on Psychopathology in Chronic Stable Schizophrenia
- (2008) Robert R. Conley et al. CLINICAL NEUROPHARMACOLOGY
- A Neuronal Microtubule-Interacting Agent, NAPVSIPQ, Reduces Tau Pathology and Enhances Cognitive Function in a Mouse Model of Alzheimer's Disease
- (2008) Y. Matsuoka et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Intranasal insulin attenuates the hypothalamic–pituitary–adrenal axis response to psychosocial stress
- (2008) Andreas Bohringer et al. PSYCHONEUROENDOCRINOLOGY
- Evidence of Dysregulated Peripheral Oxytocin Release Among Depressed Women
- (2008) Jill M. Cyranowski et al. PSYCHOSOMATIC MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started